CRUK Convergence Science Centre

@crukconvergence.bsky.social

Bringing together engineering, physical sciences, life sciences and medicine to address key questions in cancer research across @icr.ac.uk and @imperialcollegeldn.bsky.social convergencesciencecentre.ac.uk

#AACR2026 Do not miss this poster from @udaibanerji.bsky.social and team, involving work from one of our CRUK-funded PhD students, Brian Cunningham.

Udai Banerji@udaibanerji.bsky.social · 4mo ago

At #AACR26. Leveraging cancer stroma to deliver anticancer drugs. Fibroblast co-culture experiments in PDAC and sarcoma cell lines to study the role of AVA6000 a FAP activated doxorubicin prodrug as a single agent and in combination. @icr.ac.uk @crukconvergence.bsky.social

If you’re attending #AACR2026, don’t miss this poster from @udaibanerji.bsky.social and team, showcasing Centre‑supported high‑impact research from the Drug Development Unit at the ICR and The Royal Marsden

Udai Banerji@udaibanerji.bsky.social · 4mo ago

At #AACR26 Poster 6457.CD137 agonist. Exciting responses in breast cancer and high spec pharmacodynamic imaging showing decreasing metabolism (FDG-PET) but increasing lymphocytic infiltration (CD8 PET). @icr.ac.uk @royalmarsden.org @crukconvergence.bsky.social @ecmc-uk.bsky.social @nihr.bsky.social

💡 New research is shining a light on the hidden costs of living with and beyond breast cancer in the UK. At the 15th European Breast Cancer Conference, Patrick Kierkegaard, (the Centre's Implementation Science Lead) spoke to the Daily Mail about findings from the CASCARA programme.